Publikationen, an denen er mitarbeitet Iván Javier Núñez Gil (28)

2023

  1. Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry

    Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78

  2. In-hospital outcomes following percutaneous versus surgical intervention in the treatment of aortic stenosis and concomitant coronary artery disease

    Revista Espanola de Cardiologia, Vol. 76, Núm. 8, pp. 600-608

2022

  1. Differences Between Takotsubo and the Working Diagnosis of Myocardial Infarction With Nonobstructive Coronary Arteries

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. The effect of weekends and public holidays on the care of acute coronary syndrome in the Spanish National Health System

    Revista Espanola de Cardiologia, Vol. 75, Núm. 9, pp. 757-763

  3. Vascular Injury After Stenting　- Insights of Systemic Mechanisms of Vascular Repair

    Circulation journal : official journal of the Japanese Circulation Society, Vol. 86, Núm. 6, pp. 966-974

2021

  1. Evaluation of optimal medical therapy in acute myocardial infarction patients with prior stroke

    Therapeutic Advances in Chronic Disease, Vol. 12

  2. Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry

    Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966

  3. Percutaneous and surgical aortic valve replacement. Impact of volume and type of center on results

    REC: Interventional Cardiology, Vol. 3, Núm. 2, pp. 103-111

  4. Reemplazo valvular aórtico percutáneo y quirúrgico.: Influencia del volumen y del tipo de centro tratante en los resultados

    REC: Interventional Cardiology, Vol. 3, Núm. 2, pp. 103-111

  5. Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience From the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score

    Frontiers in Medicine, Vol. 8

  6. TAVI en la curva de aprendizaje en España. Resultados intrahospitalarios comparados con la sustitución valvular aórtica

    REC: CardioClinics, Vol. 56, Núm. 4, pp. 242-249

  7. TAVI in the learning curve in Spain. In-hospital results compared with aortic valve replacement

    REC: CardioClinics, Vol. 56, Núm. 4, pp. 242-249

2020

  1. Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention

    European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 7, pp. 764-770

  2. P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects

    European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42

  3. The impact of optimal medical therapy on patients with recurrent acute myocardial infarction: Subanalysis from the BleeMACS study

    International Journal of Cardiology, Vol. 318, pp. 1-6

2018

  1. Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry

    American Journal of Cardiovascular Drugs, Vol. 18, Núm. 4, pp. 299-309

  2. Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score

    International Journal of Cardiology, Vol. 254, pp. 10-15

  3. Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study

    Thrombosis Research, Vol. 168, pp. 156-163

  4. Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry

    Thrombosis and Haemostasis, Vol. 118, Núm. 5, pp. 929-938

  5. Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy

    European heart journal. Acute cardiovascular care, Vol. 7, Núm. 7, pp. 631-638